Evidence map›Paper›PMID 22025336›Full record

ReviewContrast media & molecular imaging

Advanced contrast nanoagents for photoacoustic molecular imaging, cytometry, blood test and photothermal theranostics.

Adam de la Zerda, Jin-Woo Kim, Ekaterina I Galanzha, Sanjiv S Gambhir, Vladimir P Zharov

Open access · bronzeAbstract readReview
In one paragraph

Review in Contrast media & molecular imaging. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 117 citations in OpenAlex.

  1. Article
  2. Review
  3. Molecular and cellular imaging of the eye.Biomedical optics express · 2024
    Review
  4. Review
  5. The sound of blood: photoacoustic imaging in blood analysis.Medicine in novel technology and devices · 2023
    Article
  6. Review
  7. Seeing through the Skin: Photoacoustic Tomography of Skin Vasculature and Beyond.JID innovations : skin science from molecules to population health · 2021
    Review
  8. Active matter therapeutics.Nano today · 2020
    Article
  9. Article
  10. Article
  11. Review
  12. Recent progress in photoacoustic molecular imaging.Current opinion in chemical biology · 2018
    Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Adam de la ZerdaMolecular Imaging Program at Stanford, the Bio-X Program and the Department of Radiology, Stanford University, Palo Alto, CA, USA; Department of Electrical Engineering, Stanford University, Palo Alto, CA, USA. azerda@gmail.com.
Jin-Woo Kim
Ekaterina I Galanzha
Sanjiv S Gambhir
Vladimir P Zharov
Stanford University · USUniversity of Arkansas for Medical Sciences · USUniversity of Arkansas at Fayetteville · US

Funding

Stanford Nanocharacterization LaboratoryU54CA119367 · NCI · STANFORD UNIVERSITY · PI GAMBHIR, SANJIV S · 2006 to 2010
$19.8M
Small Animal ImagingP50CA114747 · NCI · STANFORD UNIVERSITY · PI RAO, JIANGHONG · 2005 to 2014
$18.2M
In vivo real-time detection of circulating melanoma cellsR01CA131164 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI SUEN, JAMES · 2009 to 2019
$3.1M
Multifunctional nanotubes for in vivo detecting/purging circulating cancer cellsR01EB009230 · NIBIB · UNIV OF ARKANSAS FOR MED SCIS · PI ZHAROV, VLADIMIR P · 2009 to 2012
$1.2M
Photothermal Imaging of Live CellsR01EB000873 · NIBIB · UNIV OF ARKANSAS FOR MED SCIS · PI ZHAROV, VLADIMIR P · 2005 to 2008
$1.1M
In vivo molecular laser detection and treatment of circulating cancer stem cellsR21CA139373 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI ZHAROV, VLADIMIR P · 2009 to 2010
$329k
NCI NIH HHS P50 CA114747NCI NIH HHS R01 CA131164NCI NIH HHS R21 CA139373NCI NIH HHS U54 CA119367NIBIB NIH HHS R01 EB000873NIBIB NIH HHS R01 EB009230
6 · The paper itself

Abstract

Various nanoparticles have raised significant interest over the past decades for their unique physical and optical properties and biological utilities. Here we summarize the vast applications of advanced nanoparticles with a focus on carbon nanotube (CNT)-based or CNT-catalyzed contrast agents for photoacoustic (PA) imaging, cytometry and theranostics applications based on the photothermal (PT) effect. We briefly review the safety and potential toxicity of the PA/PT contrast nanoagents, while showing how the physical properties as well as multiple biological coatings change their toxicity profiles and contrasts. We provide general guidelines needed for the validation of a new molecular imaging agent in living subjects, and exemplify these guidelines with single-walled CNTs targeted to α(v) β(3) , an integrin associated with tumor angiogenesis, and golden carbon nanotubes targeted to LYVE-1, endothelial lymphatic receptors. An extensive review of the potential applications of advanced contrast agents is provided, including imaging of static targets such as tumor angiogenesis receptors, in vivo cytometry of dynamic targets such as circulating tumor cells and nanoparticles in blood, lymph, bones and plants, methods to enhance the PA and PT effects with transient and stationary bubble conjugates, PT/PA Raman imaging and multispectral histology. Finally, theranostic applications are reviewed, including the nanophotothermolysis of individual tumor cells and bacteria with clustered nanoparticles, nanothrombolysis of blood clots, detection and purging metastasis in sentinel lymph nodes, spectral hole burning and multiplex therapy with ultrasharp rainbow nanoparticles.

Indexed as

Contrast MediaAnimalsHematologic TestsHumansImage CytometryLymphatic MetastasisLymph NodesMolecular ImagingNanoparticlesNanotubes, CarbonNeoplasmsNeoplastic Cells, CirculatingNeovascularization, PathologicPhotoacoustic TechniquesContrast MediaNanotubes, Carbon

Identifiers

PMID22025336
PMCPMC4282188
OpenAlexW1927980476

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.